Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Next-Generation Dome Helmet for Focused Ultrasound Neuromodulation in Treatment-Resistant Substance Use Disorder

Official title: Assessment of Safety and Feasibility of Focused Ultrasound (FUS) Next Generation Dome Helmet (NGDH) to Perform Neuromodulation in Patients With Substance Use Disorder (SUD)

Run by Sunnybrook Health Sciences Centre · NCT07684976 · Data updated 2026-11-12

This study tests whether focused ultrasound delivered through a Dome Helmet can be safely used to target brain regions and help adults with hard-to-treat substance use disorders see if their use declines.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment20 (estimated)
SponsorSunnybrook Health Sciences Centre
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedJuly 2026
Main results expectedJuly 2028
Study endsJuly 2028
Registry record updatedJuly 6, 2026
Trial IDNCT07684976 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–70 with moderate to severe DSM-5 SUD who have tried at least two guideline-concordant pharmacotherapies and are stable on psychiatric medications.

Probably not a fit

Patients with active pregnancy, MRI-incompatible conditions, significant head injury with lesions, unstable medical illness, or severe claustrophobia may not benefit or participate.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates the safety and feasibility of using MRI-guided focused ultrasound with a Next Generation Dome Helmet to modulate activity in the nucleus accumbens and/or anterior insula in adults with treatment-resistant substance use disorder. Twenty participants will undergo two FUS sessions about four weeks apart, with comprehensive baseline assessments and follow-up safety and clinical measures. The trial aims to determine whether the procedure can be delivered safely and whether there is a signal of reduced substance use severity at four weeks post-treatment, as measured by TLFB and related outcomes. Enrollment is planned over about two years at Sunnybrook Health Sciences Centre in Toronto. Imaging, quality-of-life, and safety data will be collected to characterize feasibility and potential clinical benefit.

Why it matters

Potential benefit: If successful, the approach could offer a new, noninvasive option to reduce substance use severity in individuals with treatment-resistant SUD.

How similar studies have gone: Prior focused ultrasound neuromodulation studies have demonstrated safety signals in other neuropsychiatric contexts, but this specific dome-helmet, nucleus accumbens/anterior insula targeting for SUD is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Must be deemed to have capacity to provide informed consent (determined by the investigator)
2. Age between 18 to 70 (inclusive)
3. Diagnosis of SUD (cannabis, alcohol, ketamine, stimulant, opioid or nicotine/tobacco use disorder) in the moderate to severe range according to the DSM-5
4. Previous ≥2 pharmacotherapy trials for the diagnosed SUD according to guideline-concordant, evidence-based care
5. On a stable regimen of their psychiatric medications for 30 days before enrolment.

Exclusion Criteria:

1. Pregnant or intending to be pregnant during the study
2. Known active seizure disorder, significant head injury with an imaging verified lesion
3. Medical illness that is deemed to be unstable or may confound the effects of the intervention
4. Not eligible for 3-Tesla MRI (i.e. MRI-incompatible pacemaker)
5. Unable to reliably attend the required screening, treatment, and follow up appointments.
6. Severe claustrophobia, identified by the subject to be a limiting factor preventing MRI.
7. Scores 18 or below on Montreal Cognitive Assessment (MoCA)
8. Weighs 250 lbs or more.

Where it's running

  • Sunnybrook Health Sciences Centre
    Toronto, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.